Newswise — BOSTON – March 19, 2012 – Joslin Diabetes Center, the world’s largest diabetes research and care institution and an affiliate of Harvard Medical School, today announced the appointment of Rajni Aneja, M.D., M.B.A., C.P.E., as Executive Vice President.
John L. Brooks, President and CEO of Joslin Diabetes Center, made the announcement, saying, “Dr. Aneja brings a wealth of highly relevant experiences, strategic insights, practical ideas and management skills that are essential as we continue to demonstrate Joslin’s leadership on a global level. Her rich blend of clinical and business competencies will enable us to expand our capabilities as we fulfill our mission in all aspects of diabetes and diabetes prevention.”
Complications from diabetes are a leading cause in the U. S. of heart attacks, strokes, blindness, kidney failure, blood vessel disease that may require amputation and nerve damage. While diabetes currently affects one in 10 U.S. adults, the Centers for Disease Control forecasts that up to one in three American adults could have diabetes by 2050. Joslin is at the forefront of efforts to combat this epidemic through programs to prevent, treat and cure diabetes.
Dr. Aneja’s responsibilities will include work across all areas of Joslin to address Joslin’s numerous local, national, and global initiatives. She will be actively involved with Joslin’s partners and collaborators to create and deliver cost-effective and impactful diabetes solutions within today’s healthcare economic environment.
According to Brooks, “Dr. Aneja will be interacting with all Joslin teams to develop and deliver new diabetes treatment and prevention programs, funded with new business models, so we can enable our Joslin Inside and Joslin Everywhere strategic concepts to be utilized by our partners and collaborators to benefit patients and those at risk of diabetes across the world.”
Prior to coming to Joslin, Dr. Aneja was Chief Medical officer for WebMD health services, and in the past has held roles as the National Medical Director for Disease Management, Quality, and Standards for OptumHealth, a UnitedHealth Group company. She has been extensively involved in industry efforts to address the fundamental drivers of utilization and the quality of healthcare service delivery. She is an active contributing member of the Care Continuum Alliance (formerly the Disease Management Association of America), as well as the American College of Physician Executives.
Dr. Aneja is a certified physician executive with specialty training in family practice. She earned her medical degree from Research Medical Center in Kansas City, Missouri, and her physician executive M.B.A. from the University of Massachusetts.
About Joslin Diabetes Center
Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.
Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications.
For more information, visit www.joslin.orgKeep up with Joslin research and clinical news at Inside Joslin at www.joslin.org/news/inside_joslin.htmlBecome a fan of Joslin on Facebook at www.facebook.com/joslindiabetes Follow Joslin on Twitter @JoslinDiabetes
RSS